X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3296) 3296
Publication (303) 303
Book / eBook (75) 75
Book Review (44) 44
Book Chapter (32) 32
Conference Proceeding (3) 3
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2691) 2691
male (1780) 1780
hematology (1769) 1769
female (1763) 1763
index medicus (1670) 1670
transplantation (1516) 1516
adult (1509) 1509
middle aged (1479) 1479
oncology (1112) 1112
immunology (972) 972
stem cells (912) 912
peripheral-blood (847) 847
adolescent (833) 833
aged (802) 802
treatment outcome (770) 770
bone-marrow-transplantation (760) 760
hematopoietic stem cells (655) 655
peripheral blood stem cell transplantation (601) 601
transplantation, homologous (552) 552
retrospective studies (538) 538
care and treatment (516) 516
transplantation, autologous (504) 504
disease-free survival (497) 497
child (470) 470
versus-host-disease (470) 470
survival analysis (467) 467
health aspects (464) 464
risk factors (463) 463
bone marrow (460) 460
chemotherapy (443) 443
research (428) 428
hematopoietic stem cell transplantation (425) 425
stem cell transplantation (414) 414
animals (403) 403
young adult (401) 401
survival rate (400) 400
stem-cell transplantation (391) 391
prognosis (379) 379
therapy (376) 376
mortality (367) 367
leukemia (361) 361
antineoplastic combined chemotherapy protocols - therapeutic use (360) 360
cancer (347) 347
bone marrow transplantation (339) 339
survival (337) 337
child, preschool (330) 330
peripheral blood stem cell transplantation - methods (329) 329
transplantation conditioning - methods (316) 316
colony-stimulating factor (311) 311
peripheral blood stem cell transplantation - adverse effects (305) 305
peripheral blood (303) 303
recurrence (303) 303
bone-marrow transplantation (295) 295
follow-up studies (294) 294
peripheral vascular disease (279) 279
blood (278) 278
combined modality therapy (278) 278
hematopoietic stem cell transplantation - methods (269) 269
transplantation conditioning (266) 266
bone-marrow (258) 258
analysis (257) 257
hematopoietic stem cell transplantation - adverse effects (254) 254
graft vs host disease - prevention & control (253) 253
patients (238) 238
diagnosis (237) 237
disease (235) 235
hematologic neoplasms - therapy (235) 235
peripheral blood stem cell transplantation - mortality (231) 231
hematology, oncology and palliative medicine (230) 230
medicine (230) 230
transplants & implants (229) 229
progenitor cells (227) 227
time factors (224) 224
remission induction (223) 223
patient outcomes (222) 222
cyclophosphamide (219) 219
multiple myeloma (217) 217
graft vs host disease - etiology (215) 215
unrelated donors (215) 215
high-dose chemotherapy (212) 212
mice (210) 210
prospective studies (207) 207
acute myeloid-leukemia (201) 201
t cells (199) 199
article (197) 197
children (195) 195
graft survival (195) 195
lymphocytes (194) 194
infant (192) 192
cyclophosphamide - administration & dosage (184) 184
graft vs host disease - mortality (182) 182
risk (181) 181
antineoplastic combined chemotherapy protocols - administration & dosage (180) 180
hematologic malignancies (180) 180
multiple myeloma - therapy (180) 180
medicine, research & experimental (172) 172
hemopoiesis (164) 164
incidence (162) 162
acute disease (158) 158
relapse (157) 157
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (63) 63
St. Michael's Hospital - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Not Returned (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Hospital Department (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
Sunnybrook Health Sciences Centre - Lost (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Trillium Health Centre - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3344) 3344
Chinese (18) 18
German (13) 13
Japanese (13) 13
Spanish (8) 8
French (4) 4
Russian (4) 4
Polish (2) 2
Korean (1) 1
Romanian (1) 1
Romansh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 10/2012, Volume 367, Issue 16, pp. 1487 - 1496
In this study of unrelated-donor transplantation for hematologic cancers, survival was similar with bone marrow and peripheral-blood stem-cell grafts. However,... 
PROGENITOR CELLS | ALLOGENEIC TRANSPLANTATION | MEDICINE, GENERAL & INTERNAL | COLONY-STIMULATING FACTOR | TERM-FOLLOW-UP | RANDOMIZED-TRIAL | MALIGNANCIES | LEUKEMIA | RECIPIENTS | VERSUS-HOST-DISEASE | CHRONIC GRAFT | Recurrence | Graft vs Host Disease - epidemiology | Peripheral Blood Stem Cell Transplantation - adverse effects | Histocompatibility Testing | Humans | Bone Marrow Diseases - mortality | Kaplan-Meier Estimate | Proportional Hazards Models | Leukemia - therapy | Peripheral Blood Stem Cell Transplantation - mortality | Male | Survival Rate | Cause of Death | Graft Rejection - epidemiology | Bone Marrow Transplantation - mortality | Bone Marrow Diseases - therapy | Intention to Treat Analysis | Bone Marrow Transplantation - adverse effects | Adult | Female | Unrelated Donors | Leukemia - mortality | Patient outcomes | Stem cells | Causes of | Bone marrow | Graft versus host reaction | Transplantation | Diagnosis | Comparative analysis | Graft-versus-host reaction | Cell survival | Transplants & implants | Risk groups | Syngeneic grafts | Mortality | Clinical trials | Bone marrow transplantation | Stem cell transplantation | Cardiovascular disease | Genetic diversity | Hematopoietic stem cells | Risk factors | Quality of life | Rejection | Grafts | Motivation | Peripheral blood | Histocompatibility antigen HLA
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2017, Volume 23, Issue 3, pp. 452 - 458
Journal Article
Transplantation, ISSN 0041-1337, 08/2016, Volume 100, Issue 8, pp. 1732 - 1739
BACKGROUNDThe impact of antithymocyte globulin (ATG) in the setting of a myeloablative conditioning transplantation remains controversial, especially when... 
SURGERY | PROGNOSTIC-FACTORS | ANTITHYMOCYTE GLOBULIN | RANDOMIZED-TRIAL | RISK | IMMUNOLOGY | VERSUS-HOST-DISEASE | TRANSPLANTATION | PROPHYLAXIS | HEMATOLOGICAL MALIGNANCIES | MYELOID-LEUKEMIA | OUTCOMES | MYELODYSPLASTIC SYNDROMES | Recurrence | Whole-Body Irradiation | Peripheral Blood Stem Cell Transplantation - methods | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Bone Marrow Transplantation - methods | Graft vs Host Disease - immunology | Transplantation Conditioning - mortality | Young Adult | Time Factors | Transplantation Conditioning - methods | Antilymphocyte Serum - adverse effects | Histocompatibility Testing | Risk Factors | HLA Antigens - immunology | Peripheral Blood Stem Cell Transplantation - mortality | Leukemia, Myeloid, Acute - mortality | Bone Marrow Transplantation - mortality | Adolescent | Myelodysplastic Syndromes - mortality | Chronic Disease | Histocompatibility | Myeloablative Agonists - therapeutic use | Multivariate Analysis | Peripheral Blood Stem Cell Transplantation - adverse effects | Leukemia, Myeloid, Acute - immunology | Cyclophosphamide - therapeutic use | Antilymphocyte Serum - therapeutic use | Adult | Dose Fractionation | Female | Leukemia, Myeloid, Acute - surgery | Transplantation Conditioning - adverse effects | Unrelated Donors | Retrospective Studies | France | Myelodysplastic Syndromes - surgery | Busulfan - therapeutic use | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Chi-Square Distribution | Disease-Free Survival | Myelodysplastic Syndromes - diagnosis | Leukemia, Myeloid, Acute - diagnosis | Graft vs Host Disease - prevention & control | Immunosuppressive Agents - adverse effects | Myelodysplastic Syndromes - immunology
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9872, pp. 1116 - 1124
Summary Background Autologous haemopoietic stem-cell transplantation (HSCT) benefits patients with systemic sclerosis but has been associated with significant... 
Internal Medicine | DIAGNOSIS | RESPONSES | MEDICINE, GENERAL & INTERNAL | MULTICENTER | PULMONARY ARTERIAL-HYPERTENSION | DISEASE | GUIDELINES | TERM-FOLLOW-UP | PULSE CYCLOPHOSPHAMIDE | RIGHT HEART CATHETERIZATION | MARROW TRANSPLANTATION | Follow-Up Studies | Peripheral Blood Stem Cell Transplantation - methods | Compassionate Use Trials | Humans | Middle Aged | Male | Transplantation, Autologous | Hematopoietic Stem Cell Transplantation - mortality | Scleroderma, Diffuse - therapy | Cause of Death | Pulmonary Diffusing Capacity - physiology | Scleroderma, Diffuse - mortality | Young Adult | Scleroderma, Limited - mortality | Pericarditis, Constrictive - mortality | Adult | Female | Retrospective Studies | Heart Failure - mortality | Kaplan-Meier Estimate | Peripheral Blood Stem Cell Transplantation - mortality | Total Lung Capacity | Scleroderma, Limited - therapy | Sepsis - mortality | Scleroderma, Diffuse - physiopathology | Vital Capacity - physiology | Adolescent | Aged | Hematopoietic Stem Cell Transplantation - methods | Transplantation Conditioning | Scleroderma, Limited - physiopathology | Care and treatment | Systemic scleroderma | Scleroderma (Disease) | Transplantation | Carbon monoxide | Health aspects | Hematopoietic stem cells | Hypertension | Cytomegalovirus | Transplants & implants | Mortality | Colleges & universities | Mental health | Patients | Blood | Quality of life | Ultrasonic imaging | Stem cells | Skin | Scleroderma | Veins & arteries
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 06/2016, Volume 51, Issue 6, pp. 813 - 818
Journal Article
Cancer, ISSN 0008-543X, 04/2018, Volume 124, Issue 7, pp. 1428 - 1437
BACKGROUND Incidence of graft‐versus‐host disease (GVHD) in haploidentical bone marrow (BM) transplants using posttransplantion cyclophosphamide (PT‐Cy) is... 
stem cell source | acute graft‐versus‐host disease | haploidentical transplantation | posttransplantation cyclophosphamide | acute leukemia | acute graft-versus-host disease | SURVIVAL | ALTERNATIVE DONORS | INTENSITY | UNRELATED DONOR TRANSPLANTATION | ACUTE MYELOID-LEUKEMIA | VERSUS-HOST-DISEASE | ONCOLOGY | LEUKEMIA WORKING PARTY | OUTCOMES | HEMATOLOGIC MALIGNANCIES | REMISSION | Myeloablative Agonists - therapeutic use | Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology | Prognosis | Follow-Up Studies | Humans | Middle Aged | Male | Leukemia, Myeloid, Acute - immunology | Cyclophosphamide - therapeutic use | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Graft vs Host Disease - mortality | Adult | Female | Retrospective Studies | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Leukemia, Myeloid, Acute - therapy | Leukemia, Myeloid, Acute - pathology | Peripheral Blood Stem Cell Transplantation - mortality | Survival Rate | Combined Modality Therapy | Bone Marrow Transplantation - mortality | Adolescent | Graft vs Host Disease - prevention & control | Aged | Transplantation Conditioning | Transplantation, Haploidentical | Graft-versus-host reaction | Acute lymphatic leukemia | Transplants & implants | Myeloid leukemia | Leukemia | Bone marrow transplantation | Transplants | Transplantation | Lymphatic leukemia | Multivariate analysis | Patients | Survival | Blood | Hematopoietic stem cells | Incidence | Cyclophosphamide | Stem cells | Peripheral blood | Bone marrow | Remission | Acute myeloid leukemia | Cancer
Journal Article
Journal Article
Journal Article
Blood, ISSN 0006-4971, 03/2012, Volume 119, Issue 12, pp. 2943 - 2948
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 10, pp. 1851 - 1860
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 23, Issue 1, pp. 134 - 139
Highlights • Central nervous system infections are a significant clinical problem associated with poor survival • The 5-year cumulative incidence of central... 
Hematology, Oncology and Palliative Medicine | Encephalitis | Infections | Umbilical cord blood | Allogeneic stem cell transplantation | Neurologic complications | BONE-MARROW-TRANSPLANTATION | HUMAN HERPESVIRUS-6 ENCEPHALITIS | ADULTS | PERIPHERAL-BLOOD | IMMUNOLOGY | BUSULFAN | TRANSPLANTATION | PROPHYLAXIS | LEUKEMIA | OUTCOMES | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Bacterial Infections - etiology | Humans | Middle Aged | Toxoplasmosis - etiology | Hematopoietic Stem Cell Transplantation - mortality | Central Nervous System Infections - mortality | Incidence | Young Adult | Cord Blood Stem Cell Transplantation - adverse effects | Time Factors | Central Nervous System Infections - microbiology | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Unrelated Donors | Siblings | Central Nervous System Infections - etiology | Virus Diseases - etiology | Cord Blood Stem Cell Transplantation - methods | HLA Antigens - analysis | Adolescent | Aged | Cord Blood Stem Cell Transplantation - mortality | Hematopoietic Stem Cell Transplantation - methods | Histocompatibility | Mycoses - etiology | Histocompatibility antigens | Health aspects | HLA histocompatibility antigens | Central nervous system | Medical research | Pneumonia | Bacterial pneumonia | Antifungal agents | Mycoses | Development and progression | Transplantation | Virus diseases | Analysis | Stem cells | Medicine, Experimental
Journal Article